A systematic review and integrated analysis of biologics that target Type 2 inflammation to treat COPD with increased peripheral blood eosinophils

BACKGROUND AND AIMS: Biologics that target Type 2 inflammation are effective in reducing exacerbations of severe asthma. We conducted a systematic review and integrated analysis of the efficacy and safety of these biologics in chronic obstructive pulmonary disease (COPD) patients with increased peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnishi, Hiroshi, Eitoku, Masamitsu, Yokoyama, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218150/
https://www.ncbi.nlm.nih.gov/pubmed/35756113
http://dx.doi.org/10.1016/j.heliyon.2022.e09736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218150/
https://www.ncbi.nlm.nih.gov/pubmed/35756113
http://dx.doi.org/10.1016/j.heliyon.2022.e09736

Ejemplares similares